Viewing StudyNCT00245037



Ignite Creation Date: 2024-05-05 @ 12:07 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00245037
Status: COMPLETED
Last Update Posted: 2017-09-27
First Post: 2005-10-25

Brief Title: Busulfan Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
Sponsor: OHSU Knight Cancer Institute
Organization: OHSU Knight Cancer Institute

Organization Data

Organization: OHSU Knight Cancer Institute
Class: OTHER
Study ID: IRB00000210
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: OHSU Knight Cancer Institute
Lead Sponsor Class: OTHER
Responsible Party: Richard Maziarz
Responsible Party Title: Principal Investigator
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation: OHSU Knight Cancer Institute
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH